Home Fluorides 223104-29-8
223104-29-8,MFCD07772188
Catalog No.:AA00BF1T

223104-29-8 | 2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$19.00   $14.00
- +
2mg
98%
in stock  
$28.00   $20.00
- +
5mg
98%
in stock  
$46.00   $32.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BF1T
Chemical Name:
2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline
CAS Number:
223104-29-8
Molecular Formula:
C21H19F2NO3
Molecular Weight:
371.3773
MDL Number:
MFCD07772188
SMILES:
CCOc1ccc(c(c1)N)Oc1ccc(cc1)OCc1cc(F)ccc1F
Properties
Computed Properties
 
Complexity:
434  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
7  
XLogP3:
4.8  

Downstream Synthesis Route

[1]CurrentPatentAssignee:TAISHOPHARMACEUTICALHOLDINGSCOLTD-US6162832,2000,A

[1]DeLaCruz,GemmaGuedes;Groschner,Klaus;OliverKappe;Glasnov,TomaN.[TetrahedronLetters,2012,vol.53,#29,p.3731-3734]

[1]DeLaCruz,GemmaGuedes;Groschner,Klaus;OliverKappe;Glasnov,TomaN.[TetrahedronLetters,2012,vol.53,#29,p.3731-3734]

[1]DeLaCruz,GemmaGuedes;Groschner,Klaus;OliverKappe;Glasnov,TomaN.[TetrahedronLetters,2012,vol.53,#29,p.3731-3734]

2105-96-6   
2-(4-(2,5-difluorobenzyloxy)phenoxy)-5-ethoxyaniline 

[1]TetrahedronLetters,2012,vol.53,p.3731-3734

Literature

Title: Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivo.

Journal: Neuropharmacology 20120901

Title: Revisiting the ionic mechanisms of early afterdepolarizations in cardiomyocytes: predominant by Ca waves or Ca currents?

Journal: American journal of physiology. Heart and circulatory physiology 20120415

Title: Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers.

Journal: British journal of pharmacology 20120201

Title: SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.

Journal: Neuropharmacology 20111201

Title: The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.

Journal: Neurochemistry international 20110801

Title: Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas.

Journal: Brain research 20101202

Title: KB-R7943 inhibits Na+-dependent Mg2+ efflux in rat ventricular myocytes.

Journal: The journal of physiological sciences : JPS 20101101

Title: Pathophysiological remodeling of mouse cardiac myocytes expressing dominant negative mutant of neuron restrictive silencing factor.

Journal: Circulation journal : official journal of the Japanese Circulation Society 20101101

Title: Knockout of Na+/Ca2+ exchanger in smooth muscle attenuates vasoconstriction and L-type Ca2+ channel current and lowers blood pressure.

Journal: American journal of physiology. Heart and circulatory physiology 20100501

Title: I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.

Journal: Journal of molecular and cellular cardiology 20100101

Title: Cerebral ischemia elicits aberration in myocardium contractile function and intracellular calcium handling.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101

Title: Assessing manganese efflux using SEA0400 and cardiac T1-mapping manganese-enhanced MRI in a murine model.

Journal: NMR in biomedicine 20091001

Title: Involvement of protein kinase C in the regulation of Na+/Ca2+ exchanger in bovine adrenal chromaffin cells.

Journal: Clinical and experimental pharmacology & physiology 20090701

Title: Role of Na+/Ca2+ exchanger-mediated Ca2+ entry in pressure-induced myogenic constriction in rat posterior cerebral arteries.

Journal: Journal of pharmacological sciences 20090601

Title: Involvement of the Na(+)/Ca(2+) exchanger in the automaticity of guinea-pig pulmonary vein myocardium as revealed by SEA0400.

Journal: Journal of pharmacological sciences 20090501

Title: A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.

Journal: Journal of neuroscience research 20090301

Title: Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases.

Journal: Current medicinal chemistry 20090101

Title: Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3.

Journal: Heart rhythm 20081001

Title: Antiarrhythmic benefits of targeting the Na+/Ca2+ exchanger.

Journal: Heart rhythm 20081001

Title: Burst emergence of intracellular Ca2+ waves evokes arrhythmogenic oscillatory depolarization via the Na+-Ca2+ exchanger: simultaneous confocal recording of membrane potential and intracellular Ca2+ in the heart.

Journal: Circulation research 20080829

Title: SEA0400 fails to alter the magnitude of intracellular Ca2+ transients and contractions in Langendorff-perfused guinea pig heart.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20080701

Title: Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block.

Journal: Circulation research 20080606

Title: The ins and outs of calcium in heart failure.

Journal: Circulation research 20080606

Title: The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.

Journal: Cardiovascular research 20080601

Title: Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart.

Journal: British journal of pharmacology 20080501

Title: Intracellular mechanisms and receptor types for endothelin-1-induced positive and negative inotropy in mouse ventricular myocardium.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20080201

Title: Effect of partial blockade of the Na(+)/Ca(2+)-exchanger on Ca(2+) handling in isolated rat ventricular myocytes.

Journal: European journal of pharmacology 20071208

Title: S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias.

Journal: Journal of cardiovascular pharmacology 20071201

Title: Mechanisms of endothelin-1-induced decrease in contractility in adult mouse ventricular myocytes.

Journal: British journal of pharmacology 20071001

Title: Negative inotropic effects of endothelin-1 in mouse cardiomyocytes: evidence of a role for Na+-Ca2+ exchange.

Journal: British journal of pharmacology 20071001

Title: [Molecular pharmacologic approaches to functional analysis of new biological target molecules for drug discovery].

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20071001

Title: Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts.

Journal: British journal of pharmacology 20070801

Title: Monensin causes transient calcium ion influx into mouse splenic lymphocytes in a sodium ion-independent fashion.

Journal: European journal of pharmacology 20070430

Title: Interaction between Na+/K+-pump and Na+/Ca2+-exchanger modulates intercellular communication.

Journal: Circulation research 20070413

Title: [Na+/Ca2+ exchanger (NCX1) and cardiovascular disease].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070401

Title: Involvement of Na+-Ca2+ exchanger in cAMP-mediated relaxation in mice aorta: evaluation using transgenic mice.

Journal: British journal of pharmacology 20070201

Title: Involvement of the Na+/Ca2+ exchanger in ouabain-induced inotropy and arrhythmogenesis in guinea-pig myocardium as revealed by SEA0400.

Journal: Journal of pharmacological sciences 20070201

Title: SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.

Journal: Physiological research 20070101

Title: Anesthetic preconditioning enhances Ca2+ handling and mechanical and metabolic function elicited by Na+-Ca2+ exchange inhibition in isolated hearts.

Journal: Anesthesiology 20060901

Title: Inhibition by SEA0400, a selective inhibitor of Na+/Ca2+ exchanger, of Na+ -dependent Ca2+ uptake and catecholamine release in bovine adrenal chromaffin cells.

Journal: Journal of pharmacological sciences 20060901

Title: Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overload.

Journal: European journal of pharmacology 20060814

Title: Quantitative fluorescence measurement of cardiac Na+/Ca2+ exchanger inhibition by kinetic analysis in stably transfected HEK293 cells.

Journal: Journal of pharmacological sciences 20060801

Title: Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.

Journal: Circulation 20060704

Title: Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase.

Journal: Kidney international 20060601

Title: Sodium-dependent recovery of ionised magnesium concentration following magnesium load in rat heart myocytes.

Journal: Pflugers Archiv : European journal of physiology 20060201

Title: A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.

Journal: Journal of cardiovascular pharmacology 20060201

Title: [Na+/Ca2+ exchanger(NCX1) and salt-sensitive hypertension].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20060101

Title: Sodium calcium exchange as a target for antiarrhythmic therapy.

Journal: Handbook of experimental pharmacology 20060101

Title: Salt-sensitive hypertension, Na+/Ca2+ exchanger, and vascular smooth muscle.

Journal: Trends in cardiovascular medicine 20051101

Title: Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20050701

Title: Cardioprotection without cardiosuppression by SEA0400, a novel inhibitor of Na+-Ca2+ exchanger, during ischemia and reperfusion in guinea-pig myocardium.

Journal: Life sciences 20050603

Title: SEA-0400, a potent inhibitor of the Na+/Ca2+ exchanger, as a tool to study exchanger ionic and metabolic regulation.

Journal: American journal of physiology. Cell physiology 20050601

Title: Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchanger.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20050601

Title: Therapeutic potential of novel Na+-Ca2+ exchange inhibitors in attenuating ischemia-reperfusion injury.

Journal: The Canadian journal of cardiology 20050501

Title: SEA0400, a specific inhibitor of the Na+-Ca2+ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia.

Journal: British journal of pharmacology 20050301

Title: Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger.

Journal: Journal of pharmacological sciences 20050301

Title: Effects of SEA0400, a Na+/Ca2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs.

Journal: European journal of pharmacology 20050104

Title: Selective inhibition of sodium-calcium exchanger by SEA-0400 decreases early and delayed after depolarization in canine heart.

Journal: British journal of pharmacology 20041201

Title: Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs.

Journal: European journal of pharmacology 20041128

Title: Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1.

Journal: The Journal of pharmacology and experimental therapeutics 20041101

Title: Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle.

Journal: Nature medicine 20041101

Title: Hypertension with a grain of salt.

Journal: Nature medicine 20041101

Title: Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors.

Journal: Journal of pharmacological sciences 20040901

Title: Functional role of the Na+/H+ exchanger in the regulation of cerebral arteriolar tone in rats.

Journal: Journal of neurosurgery 20040801

Title: Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies.

Journal: The Journal of pharmacology and experimental therapeutics 20040701

Title: Na+/Ca2+ exchange inhibitors: potential drugs to mitigate the severity of ischemic injury.

Journal: Molecular pharmacology 20040701

Title: The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease.

Journal: Expert opinion on investigational drugs 20040601

Title: Cardioprotective effect of SEA0400, a selective inhibitor of the Na(+)/Ca(2+) exchanger, on myocardial ischemia-reperfusion injury in rats.

Journal: Journal of pharmacological sciences 20040601

Title: The selective Na+-Ca2+ exchange inhibitor attenuates brain edema after radiofrequency lesion in rats.

Journal: European journal of pharmacology 20040412

Title: Development and application of Na+/Ca2+ exchange inhibitors.

Journal: Molecular and cellular biochemistry 20040401

Title: Effects of SEA0400 on mutant NCX1.1 Na+-Ca2+ exchangers with altered ionic regulation.

Journal: Molecular pharmacology 20040301

Title: Molecular determinants of Na+/Ca2+ exchange (NCX1) inhibition by SEA0400.

Journal: The Journal of biological chemistry 20040227

Title: SEA0400: a novel sodium-calcium exchange inhibitor with cardioprotective properties.

Journal: Cardiovascular drug reviews 20040101

Title: Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives.

Journal: Bioorganic & medicinal chemistry letters 20031020

Title: A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury.

Journal: European journal of pharmacology 20031008

Title: Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943.

Journal: American journal of physiology. Heart and circulatory physiology 20030301

Title: Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.

Journal: European journal of pharmacology 20030101

Title: [Functional analysis of Na+/Ca2+ exchanger using novel drugs and genetically engineered mice].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021101

Title: Knockout mice for pharmacological screening: testing the specificity of Na+-Ca2+ exchange inhibitors.

Journal: Circulation research 20020726

Title: Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.

Journal: British journal of pharmacology 20020301

Title: SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models.

Journal: The Journal of pharmacology and experimental therapeutics 20010701

Title: Order and disorder at hospital meetings.

Journal: Dimensions in health service 19751201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 223104-29-8
Tags:223104-29-8 Molecular Formula|223104-29-8 MDL|223104-29-8 SMILES|223104-29-8 2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline